Darren J. Bridgewater, Jackie Ho, Victor Sauro, Douglas G. Matsell 

Slides:



Advertisements
Similar presentations
Inducible EGFR T790M-Mediated Gefitinib Resistance in Non-small Cell Lung Cancer Cells Does Not Modulate Sensitivity to PI103 Provoked Autophagy  Flavia.
Advertisements

Takehiko Wada, Jeffrey W. Pippin, Yoshio Terada, Stuart J. Shankland 
Volume 68, Issue 4, Pages (October 2005)
Harald D. Rupprecht, M.D, Yoshitaka Akagi, Annette Keil, Gerhard Hofer 
In Cardiomyocyte Hypoxia, Insulin-Like Growth Factor-I-Induced Antiapoptotic Signaling Requires Phosphatidylinositol-3-OH-Kinase-Dependent and Mitogen-Activated.
Adenosine-induced apoptosis in glomerular mesangial cells
Shear stress-stimulated endothelial cells induce smooth muscle cell chemotaxis via platelet-derived growth factor-BB and interleukin-1α  Alan Dardik,
Volume 136, Issue 1, Pages (January 2009)
Bertrand Poussier, MD, Alfredo C
Volume 63, Issue 1, Pages (January 2003)
Angiogenic effects of stromal cell-derived factor-1 (SDF-1/CXCL12) variants in vitro and the in vivo expressions of CXCL12 variants and CXCR4 in human.
Keloid Fibroblasts Resist Ceramide-Induced Apoptosis by Overexpression of Insulin- Like Growth Factor I Receptor  Hiroshi Ishihara, Hiroshi Yoshimoto,
S. Shastry, A.J. Ingram, J.W. Scholey, L.R. James  Kidney International 
Requirement of heat shock protein 90 in mesangial cell mitogenesis
The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling 
Volume 61, Issue 4, Pages (April 2002)
Volume 61, Issue 2, Pages (February 2002)
PPAR-γ agonist protects podocytes from injury
Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells  Guillermo Villegas, Bäerbel Lange-Sperandio,
C. Jacques, Ph. D. , A. D. Recklies, Ph. D. , A. Levy, F. Berenbaum, M
Volume 55, Issue 6, Pages (June 1999)
Phosphatidylinositol 3-Kinase/Akt-Dependent and -Independent Protection Against Apoptosis in Normal Human Melanocytes  Masahiro Oka, Akiko Kageyama, Mizuho.
Volume 63, Issue 3, Pages (March 2003)
Volume 64, Issue 1, Pages (July 2003)
Volume 122, Issue 5, Pages (May 2002)
Inducible EGFR T790M-Mediated Gefitinib Resistance in Non-small Cell Lung Cancer Cells Does Not Modulate Sensitivity to PI103 Provoked Autophagy  Flavia.
Volume 136, Issue 4, Pages e3 (April 2009)
Epidermal growth factor receptor inhibition attenuates early kidney enlargement in experimental diabetes  Lesley Wassef, Darren J. Kelly, Richard E. Gilbert 
Angiotensin II-induced growth of vascular smooth muscle cells requires an Src- dependent activation of the epidermal growth factor receptor1  Dirk Bokemeyer,
Hyaluronan and proximal tubular cell migration
Volume 56, Issue 4, Pages (October 1999)
Volume 64, Issue 4, Pages (October 2003)
Volume 64, Issue 2, Pages (August 2003)
Akio Horiguchi, Mototsugu Oya, Ken Marumo, Masaru Murai 
Volume 79, Issue 7, Pages (April 2011)
PDGF regulates gap junction communication and connexin43 phosphorylation by PI 3- kinase in mesangial cells  Jian Yao, Tetsuo Morioka, Takashi Oite  Kidney.
Volume 63, Issue 3, Pages (March 2003)
Volume 67, Issue 1, Pages (January 2005)
Evidence that bone morphogenetic protein 4 has multiple biological functions during kidney and urinary tract development  Yoichi Miyazaki, Keisuke Oshima,
Lysophosphatidic acid-induced proliferation in opossum kidney proximal tubular cells: Role of PI 3-kinase and ERK  Richard J. Dixon, Nigel J. Brunskill 
Plasminogen-Dependent Matriptase Activation Accelerates Plasmin Generation by Differentiating Primary Human Keratinocytes  Ya-Wen Chen, Shi Yin, Ying-Jung.
Volume 68, Issue 4, Pages (October 2005)
Advanced glycation endproducts induce podocyte apoptosis by activation of the FOXO4 transcription factor  P.Y. Chuang, Q. Yu, W. Fang, J. Uribarri, J.C.
Volume 58, Issue 3, Pages (September 2000)
Harald D. Rupprecht, M.D, Yoshitaka Akagi, Annette Keil, Gerhard Hofer 
Hyaluronan increases glomerular cyclooxygenase-2 protein expression in a p38 MAP- kinase–dependent process  Marjorie E. Dunlop, Ph.D., Evelyne E. Muggli 
Akito Maeshima, Yoshihisa Nojima, Itaru Kojima  Kidney International 
Volume 68, Issue 2, Pages (August 2005)
Volume 62, Issue 2, Pages (August 2002)
Volume 79, Issue 4, Pages (February 2011)
Volume 65, Issue 5, Pages (May 2004)
Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells  Gur P. Kaushal, Varsha Kaushal, Ph.D., Xiaoman.
Yoshihisa Ishikawa, Masanori Kitamura  Kidney International 
Volume 60, Issue 5, Pages (November 2001)
Rsk1 mediates a MEK–MAP kinase cell survival signal
Volume 67, Issue 6, Pages (June 2005)
Volume 67, Issue 4, Pages (April 2005)
Tumor necrosis factor-α and lipopolysaccharide induce apoptotic cell death in bovine glomerular endothelial cells  Udo K. Meßmer, Verena A. Briner, Josef.
Volume 59, Issue 3, Pages (March 2001)
Volume 60, Issue 3, Pages (September 2001)
MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis  Sang-Kyung Jo, Won Yong Cho, Su Ah Sung, Hyoung.
Volume 61, Issue 2, Pages (February 2002)
Volume 70, Issue 5, Pages (September 2006)
Volume 58, Issue 1, Pages (July 2000)
Volume 56, Issue 6, Pages (December 1999)
Larry D. Alexander, Suganthi Alagarsamy, Janice G. Douglas 
Volume 57, Issue 5, Pages (May 2000)
Volume 63, Issue 4, Pages (April 2003)
Differential effects of simvastatin on mesangial cells
Volume 60, Issue 2, Pages (August 2001)
Presentation transcript:

Insulin-like growth factors inhibit podocyte apoptosis through the PI3 kinase pathway  Darren J. Bridgewater, Jackie Ho, Victor Sauro, Douglas G. Matsell  Kidney International  Volume 67, Issue 4, Pages 1308-1314 (April 2005) DOI: 10.1111/j.1523-1755.2005.00208.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Characterization of the podocyte monolayer. (A) Photomicrograph demonstrating synaptopodin immunoreactivity in the podocyte monolayer. See Methods section for details (magnification ×200). (B) Western blot analysis of nephrin expression using protein extracted from cell monolayers after incubation in 1% fetal calf serum for 24, 48, and 72 hours. SeeMethods section for details. Kidney International 2005 67, 1308-1314DOI: (10.1111/j.1523-1755.2005.00208.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Insulin-like growth factor (IGF)-induced protection from apoptosis. Podocyte cell cultures were induced to undergo apoptosis using etoposide (E) and the number of apoptotic cells and total cells were counted in each of five fields as described in the Methods section. (A) Bar graph depicting the fold change in apoptotic cells in control, etoposide (200 μmol/L), and etoposide + IGF-1 (200 ng/mL)–treated cells as determined by the morphologic features associated with apoptosis. In the presence of etoposide a two- to threefold increase was observed as early as 24 hours. *P = 0.029 vs. control (N = 4). Coincubation with etoposide and IGF-1 reduced apoptosis to control levels. (B) Terminal deoxytransferase (TdT) uridine triphosphate (UTP) nick end-labeling (TUNEL) assay to detect DNA fragmentation in our cultured podocyte cell model. Green nuclei represent DNA fragmentation, a biochemical marker for apoptosis. Cells were incubated in control conditions [1% fetal bovine serum (FBS)] or induced to undergo apoptosis using etoposide in the presence or absence of IGF-1 (200 ng/mL). Error bars = SEM. Symbols are: ←, healthy cells; ◂, apoptotic cells. Kidney International 2005 67, 1308-1314DOI: (10.1111/j.1523-1755.2005.00208.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 Insulin-like growth factor (IGF)-induced phosphatidylinositol 3′-kinase(PI3K) pathway activation. (A) Total protein was extracted from cell lysates and immunoprecipitation was performed using the insulin receptor substrate-1 (IRS-1) antibody. Western blot analysis using the p85 antibody demonstrated IRS-1-p85 complex formation with a band at 85 kD as early as 5 minutes after IGF-1 stimulation. (B) Using thin-layer chromatography, phosphoinositide (PIP) phosphorylation and PIP3 production were measured after IGF-1 stimulation see Methods section for details), in the presence and absence of the PI3 kinase inhibitors LY294002 (1 μmol/L) and Wortmannin (1 μmol/L), and inhibitors of DNA and protein synthesis (cycloheximide 20 μmol/L, and Actinomycin D 1 μmol/L). IGF stimulation resulted in an approximate threefold increase in PIP3 production, an effect abrogated by coincubation with PI3K inhibitors, and unaffected by coincubation with inhibitors of new DNA and protein synthesis. P < 0.05 vs. control (N = 6). Kidney International 2005 67, 1308-1314DOI: (10.1111/j.1523-1755.2005.00208.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 4 Insulin-like growth factor (IGF)-induced AKT and bad activation. Cells were maintained in control conditions [1% fetal bovine serum (FBS)] (lane 1) or stimulated with etoposide (lane 2), etoposide + IGF-1 (200 ng/mL) (lane 3), and etoposide + IGF-1 + LY294002 (1 μmol/L) (lane 4). (A) Western blot analysis and corresponding densitometry demonstrating the changes in AKT phosphorylation. In cells incubated in the presence of IGF-1 and etoposide, AKT phosphorylation was increased compared to etoposide alone (*P = 0.03) (N = 3), an effect inhibited by coincubation of LY294002 (#P = 0.02) (N = 3). (B) Western blot analysis and corresponding densitometry demonstrating the changes in bad phosphorylation. In cells incubated in the presence of IGF-1 and etoposide, bad phosphorylation was increased compared to etoposide alone (*P = 0.002) (N = 3), an effect inhibited by coincubation of LY294002 (#P = 0.005) (N = 3). Error bars represent SEM. Kidney International 2005 67, 1308-1314DOI: (10.1111/j.1523-1755.2005.00208.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 5 Podocyte apoptosis in the presence of phosphatidylinositol 3′-kinase (PI3K) inhibitors. Cells were incubated with etoposide in the presence or absence of IGF-1 (200 ng/mL) and PI3K inhibitor, LY294002 (1 μmol/L), and assayed for morphologic features of apoptosis at 48 hours. A threefold decrease in the number of apoptotic podocytes was observed when cells were coincubated with etoposide and IGF-1 as compared to etoposide alone (*P = 0.029) (N = 4). This IGF-1–induced protective effect was fully abrogated by coincubation of cells with LY294002 (#P = 0.029) (N = 4). DMSO is dimethyl sulfoxide. Kidney International 2005 67, 1308-1314DOI: (10.1111/j.1523-1755.2005.00208.x) Copyright © 2005 International Society of Nephrology Terms and Conditions